NCT02762721View on ClinicalTrials.gov

Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples

CompletedOBSERVATIONAL
Enrollment

131

Participants

Timeline

Start Date

June 6, 2016

Primary Completion Date

April 6, 2017

Study Completion Date

April 6, 2017

Conditions
Intrahepatic CholangiocarcinomaMixed Hepatocellular CholangiocarcinomaCholangiocarcinoma
Trial Locations (6)

20089

Rozzano

20133

Milan

30322

Atlanta

56126

Pisa

82100

Benevento

98109

Seattle

All Listed Sponsors
lead

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

INDUSTRY

NCT02762721 - Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples | Biotech Hunter | Biotech Hunter